IBM
ESEN Institutional Research
IBM Systematic Research
Systematic screening of International Business Machines reveals a distinctive profit expansion cycle, with EPS growing 94.45% year-over-year to $11.31 despite the current price of $222.75 trading near the lower end of its 52-week range of $212.34–$324.90. The model indicates a technology sector participant generating above-average returns, with ROE reaching 35.53% while maintaining revenue growth of 9.67% year-over-year, signaling operational leverage in IBM's business transformation.
Core strengths identified through fundamental criteria:
- Profitability metrics surpass typical enterprise IT benchmarks, with net margin at 15.6% and operating margin at 15.32%, reflecting disciplined cost management alongside gross margin stability at 58.36%.
- The defensive beta of 0.56 positions the equity as a lower-volatility technology exposure, historically exhibiting approximately 44% less price sensitivity to broad market movements.
- The P/E ratio of 19.17 trades at a moderate premium relative to the accelerated earnings trajectory, while P/S at 2.99 remains compressed compared to cloud-native software competitors.
Risk factors flagged by quantitative screens: The D/E ratio of 1.88 exceeds conservative thresholds for technology companies, while the current ratio of 0.96 falls below the 1.0 liquidity benchmark, potentially constraining financial flexibility. The price-to-book multiple of 8.48 reflects substantial intangible asset valuation embedded in transformation initiatives.
Research perspective relative to peers Cognizant (CTSH), Gartner (IT), and EPAM Systems suggests IBM operates with significantly higher capital intensity and legacy infrastructure obligations, though ROE materially exceeds typical IT services providers in this comparison cohort.
Analysis updated monthly based on systematic screening of fundamentals, profitability, growth, and peer positioning.